133 related articles for article (PubMed ID: 36967587)
1. Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice.
Liu SQ; Deng X; Zhu CP; Cui YL; Xie WF; Zhang X
J Dig Dis; 2023 Jan; 24(1):39-50. PubMed ID: 36967587
[TBL] [Abstract][Full Text] [Related]
2. FOXA2 alleviates CCl
Wang W; Yao LJ; Shen W; Ding K; Shi PM; Chen F; He J; Ding J; Zhang X; Xie WF
Sci Rep; 2017 Nov; 7(1):15532. PubMed ID: 29138513
[TBL] [Abstract][Full Text] [Related]
3. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
5. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
6. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
[TBL] [Abstract][Full Text] [Related]
7.
Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
[TBL] [Abstract][Full Text] [Related]
8. Hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP) confers protection against hepatic fibrosis through downregulation of transforming growth factor β receptor II.
Li Q; Li H; Lv Y; Zhang Q; Zhang X; Li S; Zheng X; Wang Y; Hao Z
Lab Invest; 2020 Mar; 100(3):466-482. PubMed ID: 31641222
[TBL] [Abstract][Full Text] [Related]
9. Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice.
Jiang Y; Zhao Y; He F; Wang H
Hum Gene Ther; 2019 Feb; 30(2):179-196. PubMed ID: 30024280
[TBL] [Abstract][Full Text] [Related]
10. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH
Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture.
Hamada-Tsutsumi S; Onishi M; Matsuura K; Isogawa M; Kawashima K; Sato Y; Tanaka Y
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019495
[TBL] [Abstract][Full Text] [Related]
13. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
14. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
[TBL] [Abstract][Full Text] [Related]
15. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
18. N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice.
Shen DF; Cheng H; Cai BZ; Cai WF; Wang B; Zhu Q; Wu YB; Liu M; Chen RJ; Gao FF; Zhang YM; Niu YD; Shi GG
Acta Pharmacol Sin; 2022 Jan; 43(1):133-145. PubMed ID: 33758354
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury.
Newberry EP; Xie Y; Lodeiro C; Solis R; Moritz W; Kennedy S; Barron L; Onufer E; Alpini G; Zhou T; Blaner WS; Chen A; Davidson NO
FASEB J; 2019 Mar; 33(3):4610-4625. PubMed ID: 30576225
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.
Romero-Gallo J; Sozmen EG; Chytil A; Russell WE; Whitehead R; Parks WT; Holdren MS; Her MF; Gautam S; Magnuson M; Moses HL; Grady WM
Oncogene; 2005 Apr; 24(18):3028-41. PubMed ID: 15735717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
